Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 37 % of short-term debt in 2026; threshold 65 %.
Financials
Financial year 2026
PHARMACOSMEDICS from Knokke-Heist, company number BE0883434923, closed financial year 2026 with a result of € 5,183 after tax. For that financial year PHARMACOSMEDICS recorded a gross margin of € 10,709 and equity of € 94,092. Compared with financial year 2025, the result moved from € -26,336 to € 5,183. Profitable, and profit is growing. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on October 30, 2026.
€ 94,092
▲ 6% vs 2025
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 5,183
▲ still € 26,336 loss in 2025
Profit after tax over the fiscal year.
€ 16,063
▲ € 13,296 vs 2025
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2026. Retained profit grew to € -30,908.
Debts at end 2026
None
No bank loans on the last day of the fiscal year.
€ 88,624
▼ 7% vs 2025
Supplier invoices still open on the last day of the fiscal year.
| 2023 | 2024 | 2025 | 2026 | Change 2025 → 2026 | |
|---|---|---|---|---|---|
| Gross margin | € 2,347 | € -3,376 | € -5,766 | € 10,709 | ▲ € 16,475 |
| Profit after taxes | € 1,377 | € -4,609 | € -26,336 | € 5,183 | ▲ € 31,519 |
| Equity | € 119,855 | € 115,246 | € 88,910 | € 94,092 | ▲ 6% |
| Total debts | € 211,689 | € 197,791 | € 201,124 | € 195,208 | ▼ 3% |
| Cash | € 20,727 | € 2,288 | € 2,767 | € 16,063 | ▲ € 13,296 |
| Retained profit | € -5,145 | € -9,754 | € -36,090 | € -30,908 | ▲ € 5,183 |
| Balance sheet total | € 331,543 | € 313,036 | € 290,034 | € 289,301 |
Key figures of PHARMACOSMEDICS, fiscal years 2023 to 2026, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2027) expected before 31 October 2027.
What happened to PHARMACOSMEDICS?
What happened at PHARMACOSMEDICS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Bernard CAMBIER stepped down as director. NBB
- Anne-Sophie DE WULF stepped down as director. NBB
- Florence CAMBIER stepped down as director. NBB
- New annual accounts for financial year 2026: profit of € 5,183. Source: NBB ↗
- Bernard CAMBIER became a director. NBB
- Anne-Sophie DE WULF became a director. NBB
- Florence CAMBIER became a director. NBB
- New establishment in Gent. KBO
In short
From € 1,377 profit in 2023 to € 5,183 profit in 2026.
Best year ever: 2026, with € 5,183 profit.
Management
Directors
According to the 2026 annual accounts
since 2023 · until 2029
since 2023 · until 2029
since 2023 · until 2029
Establishments
Establishment units
Physical locations of this company
Vuurtorenstraat 14
8301 Knokke-Heist
Franklin Rooseveltlaan 234A
9000 Gent
Active since 2 November 2006
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 3 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0883.434.923
- VAT number
- BE 0883.434.923
- Registered office
- Vuurtorenstraat 14, 8301 Knokke-Heist
- Names & denominations
- PHARMACOSMEDICS · PCMS
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 29 August 2006
- Peppol
- Active · Active since 3 Mar 2025
- Activities · NACE
Speur- en ontwikkelingswerk op biotechnologisch gebied
Logistieke diensten
Organisatie van congressen en beurzen
Handelsbemiddeling in de groothandel in meubelen, huishoudelijke artikelen en ijzerwaren
Groothandel in farmaceutische en medische artikelen
Overige technische testen en toetsen
Overige vervoerondersteunende activiteiten